Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seychelle Reports Earnings for FY Period Ended February 28, 2015
Sales for subsequent First Quarter Ending May 31, 2015 are estimated to be $2.1 to $2.3 million
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--
Seychelle Water Filtration Products, a DBA of Seychelle Environmental Technologies, Inc. (Seychelle) (SYEV), a worldwide leader in the development, assembly and sale of proprietary portable water filtration bottles, made several announcements today relating to its most recent Fiscal Year’s end.
For the Fiscal Year ended February 28, 2015, Revenue was $4,305,205 compared to $5,128,461 in the prior year, a decrease of $823,356 (-16%). In addition, Net Loss of $1,405,909 was a decrease of $1,912,706 (-377%) compared to the prior year’s Net Income of $506,797. The Company incurred $1,254,791 during the fiscal year related to a lawsuit and subsequent settlement. There will be no further costs in the subsequent year related to that lawsuit.
In sharp contrast, the subsequent quarter ending May 31, 2015 shows positive results. Sales are estimated to be from $2.1 to $2.3 million, with expected net income of $400,000 to $600,000. This improvement was a result of the Company’s successful testing of fluoride reduction and the launch of its pH2O product line that increases the alkalinity of water.
“Dedicated to improving the quality of life through the quality of our drinking water.”
Note to Investors
This press release may contain certain forward-looking information about the Seychelle’s business prospects/projections. These are based upon good-faith current expectations of Seychelle’s management. Seychelle makes no representation or warranty as to the attainability of such assumptions/projections. Investors are expected to conduct their own investigation with regard to Seychelle. Seychelle assumes no obligation to update the information in this press release. For more information, please visit www.seychelle.com or call (949) 234-1999.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150601005170/en/
Contact:
Seychelle Water Filtration Products
Carl Palmer
(949) 234-1999
cpalmer@seychelle.com
Buy 10,000 shares of SYEV for the SwingTrade Portfolio at $0.35.
I added shares of OML.V / OLNCF today. I'm expecting Q2 earnings of US$0.04+. The stock closed at US$1.26. I think it is undervalued here.
ITUS Announces Uplisting to NASDAQ
LOS ANGELES, CA--(Marketwired - July 09, 2015) - ITUS Corporation ("ITUS") (ITUS) today announced that The NASDAQ Stock Market LLC has approved the listing of the Company's stock for trading on The NASDAQ Capital Market. Trading of the Company's securities on The NASDAQ Capital Market will commence effective with the opening of business on Friday, July 10, 2015.
Robert Berman, ITUS's President and CEO, stated, "NASDAQ is the market where shares of the world's most innovative and successful, high-tech companies are traded. With the potentially life saving technologies we are developing at Anixa, our cancer diagnostic subsidiary, and plans for other high-tech initiatives, NASDAQ is exactly where we want to be, and where ITUS belongs."
Shares of the Company's common stock will trade on NASDAQ under the stock symbol "ITUS." Additional information is available in the "Investors" section of the Company's website.
About ITUS Corporation
ITUS funds, develops, acquires, and licenses emerging technologies such as High-Tech, Biotechnology, Life Sciences, and Informatics. The company's wholly owned subsidiary, Anixa Diagnostics, is developing non-invasive, cancer screening tests, and the company and its other subsidiaries have ongoing development and licensing programs involving encrypted communications, advanced materials, and thin-film, flat panel displays. Additional information is available at www.ITUScorp.com.
Forward-Looking Statements: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2014 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.
ITUS Corporation: FOCUSED ON INNOVATION™
Contact:
Dean Krouch
310-484-5184
dkrouch@ITUScorp.com
OML.V is up C$0.16 to C$1.60.
This was an excellent pre-announcement by OML.V / OLNCF - http://finance.yahoo.com/news/omni-lite-reports-orders-strong-130600070.html
My top five positions are:
PFHO (largest)
RX.V
PSIX
MTSL
XPLT
Aethlon Medical Announces Nasdaq Capital Market Listing Approval
SAN DIEGO, July 8, 2015 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today announced that the Company's application to list its common stock on the Nasdaq Capital Market has been approved by The NASDAQ Stock Market LLC. Aethlon's common stock is expected to begin trading on the Nasdaq Capital Market at the opening of market hours on Monday, July 13, 2015 under its existing trading symbol, AEMD.
View photo
.Aethlon Hemopurifier.
"Trading on Nasdaq is a pivotal corporate milestone that will help raise the visibility of our therapeutic endeavors and increase the appeal of our shares to mutual funds, pension funds, and other institutional investors that may have previously been restricted from trading our shares," stated Jim Joyce, Chairman and CEO of Aethlon Medical.
About Aethlon Medical, Inc.
Aethlon Medical creates affinity biofiltration devices to treat life-threatening diseases. Our lead therapeutic candidate is the Aethlon Hemopurifier®, a first-in-class device that targets the rapid elimination of infectious viruses and cancer-promoting exosomes from the circulatory system of treated individuals. U.S. clinical progression of Hemopurifier therapy is being advanced under an FDA approved clinical study. We also provide government contracting services to the Defense Advanced Research Projects Agency related to the development of a biofiltration device to treat sepsis. Additional information can be found online at www.AethlonMedical.com or you can connect with us on on Twitter, LinkedIn, Facebook and Google+.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as "may," "believe," "anticipate," "expect," "intend," "plan," "project," "will," "projections," "estimate," or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties and actual results may differ materially from the results anticipated in the forward-looking statements. Factors that may contribute to such differences include, without limitation, the Company's ability to maintain its listing on the Nasdaq Capital Market, or any other national securities exchange, that the Company or its subsidiary will not be able to commercialize its products, that the FDA will not approve the initiation or continuation of the Company's clinical programs or provide market clearance of the Company's products, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies, the impact of government regulations, patent protection on the Company's proprietary technology, the ability of the Company to meet the milestones contemplated in its contract with DARPA, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2015, and in the Company's other filings with the Securities and Exchange Commission. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances.
Contacts:
James A. Joyce
Chairman and CEO
(Office) 858.459.7800 x301
(Cell) 619-368-2000
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Mike Smargiassi/Brad Edwards
Brainerd Communicators, Inc
212-986-6667
smarg@braincomm.com
David Zazoff
MDM Worldwide Solutions
646-403-3554
dzazoff@mdmworldwide.com
Photo - http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aethlon-medical-announces-nasdaq-capital-market-listing-approval-300110047.html
That is weird. It is different because OTC tiers and requirements are different than they once were. A few years ago they would have been listed as OTCBB because they are current on their SEC filings. However, the OTCBB doesn't exist anymore or effectively doesn't exist. They can uplist to NASDAQ any time now. They just need to get the stock price to the appropriate level. They have already filed their 8-A12B which always happens before uplist.
I don't think I have ever seen a direct uplist from pink sheets to Nasdaq. A company needs to become an SEC filer before uplisting. So, from a practical perspective that means they are going to be on the OTC for at least a little bit.
GTN hasn't been discussed here. What is the story behind it that you think will make it grow? Analysts are predicting some good growth this year and next year. It is a much bigger company than I usually invest in.
Ener-Core Announces Reverse Stock Split in Preparation for Proposed Uplisting to a National Securities Exchange
IRVINE, Calif.--(BUSINESS WIRE)--
Ener-Core, Inc. (“Ener-Core” or “the company”) (ENCR), the world’s only provider of commercialized Power Oxidation technology and equipment that generates clean power from low-quality and waste gases from a wide variety of industries, today announced that it will effect a 1-for-50 reverse stock split of the company’s authorized, issued and outstanding common stock (the “Reverse Stock Split”) in preparation for its proposed listing of its common stock on a national securities exchange (the “Proposed Listing”). Both the Reverse Stock Split and the Proposed Listing are contractual obligations of Ener-Core pursuant to a Securities Purchase Agreement, dated April 22, 2015.
“We are pleased to complete the reverse split and proceed with our preparations to list on a national securities exchange,” said Alain Castro, Chief Executive Officer of Ener-Core. “We view these actions as important steps in advancing Ener-Core’s corporate development. We believe the proposed uplisting to a national exchange will help to enhance our visibility and may provide greater liquidity to our stock. In fulfilling the reverse split commitment under our recent Securities Purchase Agreement, we also reflect our appreciation for the continued support of our stockholders who participated in that transaction.“
The Reverse Stock Split became effective with the Financial Industry Regulatory Authority (“FINRA”) as of the close of business on July 7, 2015 and will become effective with the Secretary of State of the State of Nevada as of 12:01 a.m. Eastern Time on July 8, 2015. The company’s common stock will begin trading on a split-adjusted basis at the open of business on July 8, 2015.
At the effective time of the 1-for-50 Reverse Stock Split, every 50 shares of issued and outstanding common stock will be converted into 1 share of issued and outstanding common stock, and the authorized shares of common stock will be reduced from 200,000,000 to 4,000,000 shares. All fractional shares of common stock will be rounded up to the nearest whole share. Immediately after the Reverse Stock Split becomes effective, Ener-Core will have approximately 2,463,919 shares of common stock outstanding.
Ener-Core’s common stock will trade under the ticker symbol “ENCRD” for a period of 20 business days after the Reverse Stock Split has been effected in the marketplace, and the common stock will also trade under a new CUSIP number of 29272A 206. Before any listing of the common stock on a national securities exchange can occur, Ener-Core will need to prepare, file and receive approval of an application for such listing after the Reverse Stock Split is completed. The company’s Proposed Listing is subject to review by such exchange and dependent upon the company satisfying all relevant quantitative and qualitative listing criteria of such exchange. As such, there can be no assurance that such exchange will approve the company’s application for listing.
Stockholders of record are not required to send in their current stock certificates or evidence of book-entry or other electronic positions for exchange. Following the effectiveness of the Reverse Stock Split, each stock certificate and book-entry or other electronic position representing issued and outstanding shares of the Ener-Core’s common stock will be automatically adjusted. Those stockholders holding common stock in “street name” will receive instructions from their brokers if they need to take any action in connection with the Reverse Stock Split. Stockholders should direct any questions concerning the Reverse Stock Split to their broker or Ener-Core’s transfer agent and register, VStock Transfer, LLC. VStock Transfer can be contacted at (212) 828-8436.
For additional information about the Reverse Stock Split and related administrative matters, see Ener-Core’s Current Report on Form 8-K filed July 7, 2015, available at www.sec.gov.
About Ener-Core
Irvine, California-based Ener-Core, Inc. (ENCR) designs, manufactures and has commercially deployed unique systems that generate base load, clean power from polluting waste gases including methane. Ener-Core’s patented Power Oxidizer is the only solution of its kind that turns one of the most potent pollution sources into a profitable, “always on” source of clean energy. Ener-Core’s technology offers a revolutionary alternative to the flaring (burning) of gaseous pollution while generating operating efficiencies and ensuring compliance with costly environmental regulations.
Ener-Core offers a variety of platforms including the 250kW Ener-Core Powerstation EC250 (“EC250”), the Ener-Core Power Oxidizer 333 KW Powerstation (“EC333”) and the larger counterpart, the 2MW Ener-Core Powerstation KG2-3GEF/PO.
Cautionary Statement Regarding Forward-Looking Statements
Forward-looking statements contained in this press release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Information provided by Ener-Core, such as online or printed documents, publications or information available via its website may contain forward-looking statements that involve risks, uncertainties, assumptions, and other factors, which, if they do not materialize or prove correct, could cause its results to differ materially from historical results, or those expressed or implied by such forward-looking statements. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including statements containing the words “planned,” “expects,” “believes,” “strategy,” “opportunity,” “anticipates,” and similar words. These statements may include, among others, plans, strategies, and objectives of management for future operations; any statements regarding proposed new products, services, or developments; any statements regarding future economic conditions or performance; statements of belief; and any statements of assumptions underlying any of the foregoing. The information contained in this release is as of the date of this press release. Except as otherwise expressly referenced herein, Ener-Core assumes no obligation to update forward-looking statements.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150707006604/en/
Contact:
Investor Relations:
Dian Griesel Int’l.
Enrique Briz, (212) 825-3210
or
Cheryl Schneider, (212) 825-3210
I own all of those except PKT and agree with you.
Does anyone see something on this list that looks like a good pick and hasn't been discussed here? Many times, the next winner is one that already was a winner.
http://microcapclub.com/2015/06/microcaps-with-the-highest-return-over-the-last-5-years/
Does anyone see something on this list that looks like a good pick and hasn't been discussed here? Many times, the next winner is one that already was a winner.
http://microcapclub.com/2015/06/microcaps-with-the-highest-return-over-the-last-5-years/
CUBN uplists...
Commerce Union Bancshares, Inc. Approved to Trade on Nasdaq
BRENTWOOD, Tenn.--(BUSINESS WIRE)--
Commerce Union Bancshares, Inc. announced today that received approval for its stock to trade on The Nasdaq Stock Market. Commerce Union’s stock will begin trading on The Nasdaq Stock Market effective July 7, 2015 under the stock symbol CUBN.
“We are pleased to announce that Commerce Union Bancshares’ stock will begin trading on The Nasdaq Stock Market effective July 7th,” stated William R. DeBerry, Chairman and Chief Executive Officer. “We believe the Nasdaq listing will provide increased visibility for our company with investors and increased marketability of our shares for our stockholders.”
Commenting on the listing, DeVan Ard, President of Commerce Union stated, “The Nasdaq listing represents an important milestone in our combination of Commerce Union and Reliant banks. The merger strengthened our capital base, increased our lending limits, expanded the reach of our combined banks and improved our operating synergies. We believe the Nasdaq listing highlights our continued progress to build long-term shareholder value by combining our resources.”
About Commerce Union Bancshares, Inc. and Commerce Union Bank
Commerce Union Bank is a full-service commercial bank that offers a variety of deposit, lending and mortgage products and services to business and consumer customers located in Davidson, Robertson, Rutherford, Sumner and Williamson Counties, Tennessee. Commerce Union Bancshares’ stock is traded on The Nasdaq Stock Market under the symbol “CUBN.” For additional information, locations and hours of operation, please visit www.commerceunionbank.com.
Forward-Looking Statements
Statements in this press release relating to Commerce Union Bancshares’ plans, objectives, expectations or future performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “should,” “anticipate,” “estimate,” “expect,” “intend,” “objective,” “possible,” “seek,” “plan,” “strive” or similar words, or negatives of these words, identify forward-looking statements. These forward-looking statements are based on management’s current expectations. The Company’s actual results in future periods may differ materially from those indicated by forward-looking statements due to various risks and uncertainties. These risks and uncertainties are described in greater detail under “Risk Factors” in the Company’s most recent annual report on Form 10-K and subsequent periodic reports filed with the Securities and Exchange Commission. The forward-looking statements in this press release are made as of the date of the release and the Company does not assume any responsibility to update these statements.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150706005554/en/
Contact:
Commerce Union Bank
DeVan Ard, 615-221-2020
President and Chief Executive Officer
or
Commerce Union Bancshares, Inc.
Ron DeBerry, 615-433-7200
Chairman and Chief Executive Officer
S&P futures are down due to the no vote on the referendum in Greece. I suspect that overall (not necessarily Monday) the market response to the problem in Greece will represent a buying opportunity.
http://finance.yahoo.com/q?s=esu15.cme
http://finance.yahoo.com/news/greece-votes-referendum-future-euro-042002010.html
Here is an interesting article that I found that is related to SCKT.
http://www.ingrammicroadvisor.com/data-capture/7-trends-driving-the-tablet-point-of-sale-market
MTSL, which last traded at $2.75, is trading at less than the last insider purchase of 20,000 shares at $3 by the COB.
See Item #3 in the link below:
http://www.sec.gov/Archives/edgar/data/1025561/000091066215000106/sc13da.htm
Thanks. My dancing is nowhere near that good. LOL
I'm the #1 ranked investor on MicroCapClub - http://microcapclub.com/about/ranking/
Good updates....Thanks.
Yes sir!
EACO reports a nice record quarter...
http://finance.yahoo.com/news/eaco-corporation-reports-record-quarterly-200100733.html
I wrote part 4 of my investing and trading philosophy entitled My Secret Recipe.
http://microcapclub.com/2015/06/my-secret-recipe-the-bargain-rack/
Thanks. I may write a book some day.
I added to BIOYF and PSIX today.
Thanks.
I wrote a new article - My Secret Recipe: The Bargain Rack
http://microcapclub.com/2015/06/my-secret-recipe-the-bargain-rack/
The author certainly likes the stock and wants it higher. While backlog is down, it isn't the only way to look at their future. They will have lots of demand for their product over the long term as customers have to convert. I look at backlog as a medium term metric.
PSIX - Here is the CNBC interview where Paul Meeks of Saturna Capital mentions PSIX.
http://video.cnbc.com/gallery/?video=3000391946
They should just follow the platinum portfolio here (aka SwingTrade Portfolio). :)
They finally started listening to me. It is about time. :)
What did they say? I missed it.
A Seeking Alpha article is out on TIK.
http://seekingalpha.com/article/3283875-serial-loser-turns-the-corner-and-posts-big-numbers-buy-the-dip
PSIX presented at Global Hunter two days ago. The webcast was archived along with the slide. It is a good background on them.
http://investors.psi....com/events.cfm
ITUS Announces Reverse Stock Split With the Intention to List Shares on NASDAQ
LOS ANGELES, CA--(Marketwired - June 25, 2015) - ITUS Corporation ("ITUS") (ITUS), today announced that effective at 9:00 a.m. Eastern Standard Time on Friday, June 26, 2015, the company will implement a 1 for 25 reverse stock split of its common shares. The company's common stock will begin trading on a post-reverse stock split basis on the OTCQB under the temporary symbol "ITUSD" effective with the open of business on June 26, 2015. The company's shareholders approved implementation of a reverse stock split on August 8, 2014, and the company's board of directors has determined to take such action to help the company become eligible for listing on The NASDAQ Stock Market.
Robert Berman, ITUS's President and CEO, stated, "The excessively large number of outstanding ITUS shares has been an ongoing concern raised by investors and others in the financial community. With the announcement of our new business direction and the launch of exciting initiatives such as Anixa, our cancer diagnostics subsidiary, the timing is right to clean up the capital structure of the company as we complete our transformation and position the company for long term success."
As a result of the reverse stock split, every 25 shares of ITUS's issued and outstanding shares of common stock will be automatically converted into 1 share of common stock. Any fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share. Additionally, as a result of the reverse stock split the number of shares of ITUS's common stock and preferred stock authorized under our Certificate of Incorporation, as amended, will be decreased by the same proportion as the outstanding shares of common stock.
The reverse stock split will reduce the number of ITUS's issued and outstanding common stock from approximately 219 million shares, pre-reverse stock split, to approximately 8.8 million shares, post-reverse stock split. In most instances, the only way to obtain new ITUS share certificates will be to physically exchange old share certificates. To facilitate a smooth transition, we recommend that shareholders first obtain possession of their physical stock certificates. If necessary, shareholders should request such certificates from their brokers, if they have not already done so. Shareholders will receive detailed instructions for obtaining new share certificates from the company's transfer agent within the next 6 weeks, and instructions will also be made available in the "Investor" section of the ITUS website. A new CUSIP number of 45069V203 will replace the pre-reverse split CUSIP number of 45069V104 to distinguish between the company's pre- and post-reverse split shares of common stock.
About ITUS Corporation
ITUS funds, develops, acquires, and licenses emerging technologies such as High-Tech, Biotechnology. Life Sciences, and Informatics. The company has ongoing licensing programs involving encrypted communications, and advanced materials, and an ongoing development program to create highly efficient, flat panel displays, utilizing a proprietary technology for carbon Nanotubes and phosphor luminescence. Additional information is available at www.ITUScorp.com.
Forward-Looking Statements: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2014 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.
ITUS Corporation: FOCUSED ON INNOVATION™
Contact:
Ron Tenio
310-484-5197
rtenio@ITUScorp.com
Dean Krouch
310-484-5184
dkrouch@ITUScorp.com
TIK reports non-GAAP EPS of $0.21.
http://finance.yahoo.com/news/tel-instrument-electronics-corp-reports-120000212.html